BIIB Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Biogen Inc. Stock Analysis BIIB
United States Health Care Large Cap Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,605 full-time employees. The firm is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. The company operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The company is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. The company also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).
Read More BIIB Chart
Biogen Inc vs S&P 500 Comparative Returns
Analysis of BIIB stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Biogen Inc (BIIB) -22.58%
- S&P 500 -4.27%
Biogen Inc Underperformed S&P 500 by 18.31%
1Y Performance
- Biogen Inc (BIIB) -46.12%
- S&P 500 8.86%
Biogen Inc Underperformed S&P 500 by 54.98%
3Y Performance
- Biogen Inc (BIIB) -36.87%
- S&P 500 37.21%
Biogen Inc Underperformed S&P 500 by 74.08%
5Y Performance
- Biogen Inc (BIIB) -62.3%
- S&P 500 92.3%
Biogen Inc Underperformed S&P 500 by 154.60%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$118.75Volume
1.87MP/E Ratio (TTM)
10.4752 Week Range
Market Cap
20.73BAvg. Volume
1.68MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 88.45 | 74.71 | 70.65 | 67.88 | - |
EBIT per Share (TTM) | 32.73 | 23.78 | 22.39 | 15.01 | - |
Earnings per Share (EPS) (TTM) | 24.86 | 10.44 | 20 | 8 | - |
EPS Forward | - | - | 20.87 | 7.97 | 11.19 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Joel Greenblatt
% Portfolio:
0.13 Recent Activity:111.16%
Ken Fisher
% Portfolio:
0.01 Recent Activity:170.97%
Jefferies Group
% Portfolio:
0 Recent Activity:-
Community-Curated Collections ( With BIIB )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
Nasdaq-100 Index
By Dilnoza Mirsaidova
61 Followers
Halal stocks in Nasdaq 100 index
By Investment Alchemist
9 Followers
Yaxshi
By Yusupov Abdurauf
3 Followers
Halal Healthcare
By Hisham Ziad
2 Followers
My Watchlist
1 Followers
Nasdaq 100
By Abdelhalim Osman
1 Followers
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
